Login / Signup

Substituted N-(Pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-Infective Evaluation, Cytotoxicity, and In Silico Studies.

Ghada BouzMartin JuhásLluis Pausas OteroCristina Paredes de la RedOndřej JanďourekKlára KonečnáPavla PaterováVladimír KubíčekJiří JanoušekMartin DoležalFotios Tsopelas
Published in: Molecules (Basel, Switzerland) (2019)
We prepared a series of substituted N-(pyrazin-2-yl)benzenesulfonamides as an attempt to investigate the effect of different linkers connecting pyrazine to benzene cores on antimicrobial activity when compared to our previous compounds of amide or retro-amide linker type. Only two compounds, 4-amino-N-(pyrazin-2-yl)benzenesulfonamide (MIC = 6.25 μg/mL, 25 μM) and 4-amino-N-(6-chloropyrazin-2-yl)benzenesulfonamide (MIC = 6.25 μg/mL, 22 μM) exerted good antitubercular activity against M. tuberculosis H37Rv. However, they were excluded from the comparison as they-unlike the other compounds-possessed the pharmacophore for the inhibition of folate pathway, which was proven by docking studies. We performed target fishing, where we identified matrix metalloproteinase-8 as a promising target for our title compounds that is worth future exploration.
Keyphrases
  • molecular docking
  • mycobacterium tuberculosis
  • molecular dynamics
  • molecular dynamics simulations
  • case control
  • emergency department
  • small molecule
  • hepatitis c virus
  • hiv aids
  • adverse drug